CareDx Inc
NASDAQ:CDNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CareDx Inc
NASDAQ:CDNA
|
US |
|
Tokyo Century Corp
F:59O
|
JP |
|
Enerflex Ltd
TSX:EFX
|
CA |
Intrinsic Value
The intrinsic value of CareDx Inc (CDNA) under the Base Case is 36.1168 USD per share.
Compared with the current market price of 69.9899 USD, the stock appears
Overvalued by 48% .
The intrinsic value is calculated using the DCF method. Net margin recovers from -5.6% last year to 14% by 2036. If net margin stayed at its five-year average of -18%, the estimate would be about $6.59. The value of the years after 2036 is tied to revenue, so margins count only until then.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What CareDx Does
CareDx makes tests and related tools for organ transplant patients and the doctors who care for them. Its main products help hospitals and transplant centers match donors and recipients before surgery and then monitor whether the patient’s body is accepting the new organ afterward. The company also sells lab services and software that help transplant teams track results and manage patient follow-up.
- Headquarters
- United States of America US
- Employees
- 761
- IPO date
- Jul 17, 2014
CareDx has no economic moat
CareDx Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Revenue & Expenses Breakdown
CareDx Inc
Earnings Waterfall
CareDx Inc
The intrinsic value for CareDx Inc (CDNA) under the Base Case is 36.1168 USD.
Compared with the current market price of 69.9899 USD, the stock appears Overvalued by 48% .